B cells are particularly important for CD4 T cell priming, and Bregs are important for suppressing CD4 T cell responses, so we hypothesized that MEK inhibition would specifically augment the number of tumor infiltrating CD4 T cells. The gene discussed is MAP2K7; the disease is neoplasm.